<p>随着全球市场在复杂的环境中航行，小型股和价值股逐渐受到关注，投资者越来越多地关注亚洲那些不为人知的机会。尽管便士股票常常被视为过去交易日的遗物，但在强劲的财务支持下，它们仍然具有显著增长的潜力。本文探讨了三只在资产负债表强度和发掘当前市场隐藏价值方面表现突出的亚洲便士股票。</p>
<h3>亚洲十大便士股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.44</td>
<td>HK$890.67M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)</td>
<td>THB2.62</td>
<td>THB1.1B</td>
<td>✅ 3 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.48</td>
<td>HK$2.06B</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Atlantic Navigation Holdings (Singapore) (Catalist:5UL)</td>
<td>SGD0.122</td>
<td>SGD63.87M</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>Halcyon Technology (SET:HTECH)</td>
<td>THB2.96</td>
<td>THB888M</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD3.45</td>
<td>SGD13.58B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Anton Oilfield Services Group (SEHK:3337)</td>
<td>HK$0.96</td>
<td>HK$2.54B</td>
<td>✅ 3 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>NagaCorp (SEHK:3918)</td>
<td>HK$4.42</td>
<td>HK$19.55B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Livestock Improvement (NZSE:LIC)</td>
<td>NZ$1.00</td>
<td>NZ$137.01M</td>
<td>✅ 2 ⚠️ 5 查看分析 </td>
</tr>
<tr>
<td>Bosideng International Holdings (SEHK:3998)</td>
<td>HK$4.53</td>
<td>HK$52.62B</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
</tbody>
</table>
<p>点击这里查看我们亚洲便士股票筛选器中的 947 只股票的完整列表。</p>
<p>以下是筛选器中一些选择的预览。</p>
<h2>LifeTech Scientific (SEHK:1302)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> LifeTech Scientific Corporation 是一家投资控股公司，专注于开发、制造和交易用于心血管和外周血管疾病的介入医疗设备，业务覆盖中国大陆及多个国际市场，市值为 HK$83.8 亿。</p>
<p><strong>运营：</strong> 公司的收入来自三个主要业务板块：结构性心脏病业务（CN¥5.2787 亿）、外周血管疾病业务（CN¥7.6208 亿）和心脏起搏与电生理业务（CN¥3763 万）。</p>
<p><strong>市值：</strong> HK$83.8 亿</p>
<p>LifeTech Scientific 以 HK$83.8 亿的市值因近期产品批准和介入医疗设备的创新而受到关注。该公司已获得其 G-iliac™ Pro 支架系统和 CS™支架 - 移植物系统的监管批准，预计将显著增强其产品组合。尽管过去五年盈利下降且近期出现负增长，LifeTech 仍然无债务，短期资产覆盖负债的能力强。然而，管理层的任期有限可能在他们应对竞争激烈的行业动态和通过创新解决方案实现收入增长时带来挑战。</p>
<ul>
<li>点击这里发现 LifeTech Scientific 的细微差别，查看我们的详细财务健康报告。</li>
<li>查看 LifeTech Scientific 的历史业绩报告，以了解其在过去几年的表现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f4cde0c9-3c8c-4906-8b2c-0faa80c9ae86/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f4cde0c9-3c8c-4906-8b2c-0faa80c9ae86/chart/debt-equity-history-analysis"/></p>
<p>截至 2026 年 1 月的 SEHK:1302 债务与股本历史及分析</p>
<h2>United Energy Group (SEHK:467)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> United Energy Group Limited 是一家投资控股公司，涉及巴基斯坦、南亚、中东和北非的上游石油、天然气、清洁能源和能源交易业务，市值约为 HK$124.1 亿。</p>
<p><strong>运营：</strong> 该公司通过其交易业务产生的收入为 HK$79.9 亿，勘探和生产活动的收入总计为 HK$91.3 亿。</p>
<p><strong>市值：</strong> HK$124.1 亿</p>
<p>United Energy Group 以 HK$124.1 亿的市值，尽管过去五年盈利年均下降 19.2%，但最近已实现盈利。该公司受益于强大的现金储备，超过其总债务，并且 EBIT 的利息覆盖率为 44.4 倍，表明在波动性降低的情况下财务稳定。然而，挑战包括管理团队和董事会经验不足，平均任期仅为 0.6 年，以及短期负债超过资产 HK$14 亿，尽管盈利质量高，但股息未能得到盈利或自由现金流的良好覆盖。</p>
<ul>
<li>点击探索我们在 United Energy Group 财务健康报告中的详细发现。</li>
<li>查看我们的历史业绩报告，以获取关于 United Energy Group 的业绩记录的见解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2508be64-00a3-48b7-8fbc-63c2c5323748/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2508be64-00a3-48b7-8fbc-63c2c5323748/chart/debt-equity-history-analysis"/></p>
<p>截至 2026 年 1 月的 SEHK:467 债务与股本历史及分析</p>
<h2>InnoTek (SGX:M14)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> InnoTek Limited 是一家投资控股公司，在香港、中国大陆、泰国和越南制造精密金属组件，市值为 SGD172.63 百万。</p>
<p><strong>运营：</strong> 公司的收入来自其 Mansfield 部门，精密加工收入为 SGD35.04 百万，精密组件和工具收入为 SGD279.71 百万。</p>
<p><strong>市值：</strong> SGD172.63 百万</p>
<p>InnoTek Limited，市值为 1.7263 亿新加坡元，展现出财务韧性，因为其现金储备超过总债务，短期资产覆盖长期和短期负债。然而，该公司面临过去五年盈利下降的挑战，股本回报率仅为 1.5%。尽管整体盈利质量较高，但股息支付并未得到盈利的良好支持。最近的董事会变动可能带来战略转变，但并未立即解决盈利能力问题或改善净利润率，后者在过去一年中从 1.9% 降至 1.4%。</p>
<ul>
<li>点击此链接查看 InnoTek 的完整分析健康报告，以深入了解该公司。</li>
<li>通过查看我们的业绩历史报告，了解 InnoTek 的过往表现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/12da91b7-f162-4c43-bee1-d9294ba5d487/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/12da91b7-f162-4c43-bee1-d9294ba5d487/chart/debt-equity-history-analysis"/></p>
<p>截至 2026 年 1 月的 SGX:M14 债务与股本历史及分析</p>
<h2>将想法转化为行动</h2>
<ul>
<li>点击此链接深入了解我们亚洲便士股票筛选器中的 947 家公司。</li>
<li>想要探索一些替代方案？通过提供可靠收入来源的稳健股息支付者来多样化您的投资组合，以应对潜在的市场动荡。</li>
</ul>
<p><em>本文由 Simply Wall St 撰写，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，采用无偏见的方法，我们的文章并不构成财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均没有持仓。</em></p>

先健科技

利华控股集团

东江集团控股

<p>随着全球市场的变化，投资者正关注亚洲的低价股票以寻求增长。本文重点介绍了三只有前景的股票：利华控股集团（SEHK:1346），市值为 8.9067 亿港元；亚洲医学与农业实验室（SET:AMARC），市值为 11 亿泰铢；以及东江集团控股（SEHK:2283），市值为 20.6 亿港元。每只股票都显示出强劲的财务状况和价值发现的潜力。此外，先健科技（SEHK:1302）和联合能源集团（SEHK:467）也被提及，市值分别为 83.8 亿港元和 124.1 亿港元，尽管面临盈利和管理经验方面的挑战</p>

<p>As global markets navigate a mixed landscape, with small-cap and value stocks gaining traction, investors are increasingly looking toward under-the-radar opportunities in Asia. Penny stocks, though often considered a relic of past trading days, still hold potential for significant growth when backed by strong financials. In this article, we explore three Asian penny stocks that stand out for their balance sheet strength and potential to uncover hidden value in today's market.</p>
<div class="lb-trans"><p>随着全球市场在复杂的环境中航行，小型股和价值股逐渐受到关注，投资者越来越多地关注亚洲那些不为人知的机会。尽管便士股票常常被视为过去交易日的遗物，但在强劲的财务支持下，它们仍然具有显著增长的潜力。本文探讨了三只在资产负债表强度和发掘当前市场隐藏价值方面表现突出的亚洲便士股票。</p>
</div><h3>Top 10 Penny Stocks In Asia</h3>
<div class="lb-trans"><h3>亚洲十大便士股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.44</td>
<td>HK$890.67M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)</td>
<td>THB2.62</td>
<td>THB1.1B</td>
<td>✅ 3 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.48</td>
<td>HK$2.06B</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Atlantic Navigation Holdings (Singapore) (Catalist:5UL)</td>
<td>SGD0.122</td>
<td>SGD63.87M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Halcyon Technology (SET:HTECH)</td>
<td>THB2.96</td>
<td>THB888M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD3.45</td>
<td>SGD13.58B</td>
<td>✅ 5 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Anton Oilfield Services Group (SEHK:3337)</td>
<td>HK$0.96</td>
<td>HK$2.54B</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>NagaCorp (SEHK:3918)</td>
<td>HK$4.42</td>
<td>HK$19.55B</td>
<td>✅ 5 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Livestock Improvement (NZSE:LIC)</td>
<td>NZ$1.00</td>
<td>NZ$137.01M</td>
<td>✅ 2 ⚠️ 5 View Analysis &gt;</td>
</tr>
<tr>
<td>Bosideng International Holdings (SEHK:3998)</td>
<td>HK$4.53</td>
<td>HK$52.62B</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.44</td>
<td>HK$890.67M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)</td>
<td>THB2.62</td>
<td>THB1.1B</td>
<td>✅ 3 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.48</td>
<td>HK$2.06B</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Atlantic Navigation Holdings (Singapore) (Catalist:5UL)</td>
<td>SGD0.122</td>
<td>SGD63.87M</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>Halcyon Technology (SET:HTECH)</td>
<td>THB2.96</td>
<td>THB888M</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD3.45</td>
<td>SGD13.58B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Anton Oilfield Services Group (SEHK:3337)</td>
<td>HK$0.96</td>
<td>HK$2.54B</td>
<td>✅ 3 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>NagaCorp (SEHK:3918)</td>
<td>HK$4.42</td>
<td>HK$19.55B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Livestock Improvement (NZSE:LIC)</td>
<td>NZ$1.00</td>
<td>NZ$137.01M</td>
<td>✅ 2 ⚠️ 5 查看分析 </td>
</tr>
<tr>
<td>Bosideng International Holdings (SEHK:3998)</td>
<td>HK$4.53</td>
<td>HK$52.62B</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 947 stocks from our Asian Penny Stocks screener.</p>
<div class="lb-trans"><p>点击这里查看我们亚洲便士股票筛选器中的 947 只股票的完整列表。</p>
</div><p>Here's a peek at a few of the choices from the screener.</p>
<div class="lb-trans"><p>以下是筛选器中一些选择的预览。</p>
</div><h2>LifeTech Scientific (SEHK:1302)</h2>
<div class="lb-trans"><h2>LifeTech Scientific (SEHK:1302)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> LifeTech Scientific Corporation is an investment holding company that develops, manufactures, and trades interventional medical devices for cardiovascular and peripheral vascular diseases across Mainland China and various international markets, with a market cap of HK$8.38 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> LifeTech Scientific Corporation 是一家投资控股公司，专注于开发、制造和交易用于心血管和外周血管疾病的介入医疗设备，业务覆盖中国大陆及多个国际市场，市值为 HK$83.8 亿。</p>
</div><p><strong>Operations:</strong> The company's revenue is derived from three main segments: Structural Heart Diseases Business (CN¥527.87 million), Peripheral Vascular Diseases Business (CN¥762.08 million), and Cardiac Pacing and Electrophysiology Business (CN¥37.63 million).</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入来自三个主要业务板块：结构性心脏病业务（CN¥5.2787 亿）、外周血管疾病业务（CN¥7.6208 亿）和心脏起搏与电生理业务（CN¥3763 万）。</p>
</div><p><strong>Market Cap:</strong> HK$8.38B</p>
<div class="lb-trans"><p><strong>市值：</strong> HK$83.8 亿</p>
</div><p>LifeTech Scientific, with a market cap of HK$8.38 billion, is gaining attention due to recent product approvals and innovations in interventional medical devices. The company has secured regulatory approval for its G-iliac™ Pro stent system and the CS™ Stent-Graft System, which are expected to enhance its product portfolio significantly. Despite a decline in earnings over the past five years and recent negative growth, LifeTech remains debt-free with strong short-term asset coverage over liabilities. However, management's limited tenure may pose challenges as they navigate competitive industry dynamics and aim for revenue growth through innovative solutions.</p>
<div class="lb-trans"><p>LifeTech Scientific 以 HK$83.8 亿的市值因近期产品批准和介入医疗设备的创新而受到关注。该公司已获得其 G-iliac™ Pro 支架系统和 CS™支架 - 移植物系统的监管批准，预计将显著增强其产品组合。尽管过去五年盈利下降且近期出现负增长，LifeTech 仍然无债务，短期资产覆盖负债的能力强。然而，管理层的任期有限可能在他们应对竞争激烈的行业动态和通过创新解决方案实现收入增长时带来挑战。</p>
</div><ul>
<li>Click here to discover the nuances of LifeTech Scientific with our detailed analytical financial health report.</li>
<li>Examine LifeTech Scientific's past performance report to understand how it has performed in prior years.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里发现 LifeTech Scientific 的细微差别，查看我们的详细财务健康报告。</li>
<li>查看 LifeTech Scientific 的历史业绩报告，以了解其在过去几年的表现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f4cde0c9-3c8c-4906-8b2c-0faa80c9ae86/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/f4cde0c9-3c8c-4906-8b2c-0faa80c9ae86/chart/debt-equity-history-analysis"/></p>
<p>SEHK:1302 Debt to Equity History and Analysis as at Jan 2026</p>
<div class="lb-trans"><p>截至 2026 年 1 月的 SEHK:1302 债务与股本历史及分析</p>
</div><h2>United Energy Group (SEHK:467)</h2>
<div class="lb-trans"><h2>United Energy Group (SEHK:467)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> United Energy Group Limited is an investment holding company involved in upstream oil, natural gas, clean energy, and energy trading operations across Pakistan, South Asia, the Middle East, and North Africa with a market cap of approximately HK$12.41 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> United Energy Group Limited 是一家投资控股公司，涉及巴基斯坦、南亚、中东和北非的上游石油、天然气、清洁能源和能源交易业务，市值约为 HK$124.1 亿。</p>
</div><p><strong>Operations:</strong> The company generates revenue from its trading operations amounting to HK$7.99 billion and exploration and production activities totaling HK$9.13 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司通过其交易业务产生的收入为 HK$79.9 亿，勘探和生产活动的收入总计为 HK$91.3 亿。</p>
</div><p><strong>Market Cap:</strong> HK$12.41B</p>
<div class="lb-trans"><p><strong>市值：</strong> HK$124.1 亿</p>
</div><p>United Energy Group, with a market cap of HK$12.41 billion, has recently become profitable despite a 19.2% annual decline in earnings over the past five years. The company benefits from strong cash reserves exceeding its total debt and robust interest coverage of 44.4 times EBIT, indicating financial stability amidst volatility reduction from 10% to 5%. However, challenges include an inexperienced management team and board with an average tenure of just 0.6 years, alongside short-term liabilities surpassing assets by HK$1.4 billion and a dividend not well covered by earnings or free cash flows despite high-quality earnings.</p>
<div class="lb-trans"><p>United Energy Group 以 HK$124.1 亿的市值，尽管过去五年盈利年均下降 19.2%，但最近已实现盈利。该公司受益于强大的现金储备，超过其总债务，并且 EBIT 的利息覆盖率为 44.4 倍，表明在波动性降低的情况下财务稳定。然而，挑战包括管理团队和董事会经验不足，平均任期仅为 0.6 年，以及短期负债超过资产 HK$14 亿，尽管盈利质量高，但股息未能得到盈利或自由现金流的良好覆盖。</p>
</div><ul>
<li>Click to explore a detailed breakdown of our findings in United Energy Group's financial health report.</li>
<li>Review our historical performance report to gain insights into United Energy Group's track record.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击探索我们在 United Energy Group 财务健康报告中的详细发现。</li>
<li>查看我们的历史业绩报告，以获取关于 United Energy Group 的业绩记录的见解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2508be64-00a3-48b7-8fbc-63c2c5323748/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/2508be64-00a3-48b7-8fbc-63c2c5323748/chart/debt-equity-history-analysis"/></p>
<p>SEHK:467 Debt to Equity History and Analysis as at Jan 2026</p>
<div class="lb-trans"><p>截至 2026 年 1 月的 SEHK:467 债务与股本历史及分析</p>
</div><h2>InnoTek (SGX:M14)</h2>
<div class="lb-trans"><h2>InnoTek (SGX:M14)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> InnoTek Limited is an investment holding company that manufactures precision metal components in Hong Kong, the People’s Republic of China, Thailand, and Vietnam, with a market cap of SGD172.63 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> InnoTek Limited 是一家投资控股公司，在香港、中国大陆、泰国和越南制造精密金属组件，市值为 SGD172.63 百万。</p>
</div><p><strong>Operations:</strong> The company's revenue is derived from its Mansfield division, with SGD35.04 million from Precision Machining and SGD279.71 million from Precision Components and Tooling.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入来自其 Mansfield 部门，精密加工收入为 SGD35.04 百万，精密组件和工具收入为 SGD279.71 百万。</p>
</div><p><strong>Market Cap:</strong> SGD172.63M</p>
<div class="lb-trans"><p><strong>市值：</strong> SGD172.63 百万</p>
</div><p>InnoTek Limited, with a market cap of SGD172.63 million, demonstrates financial resilience as its cash reserves exceed total debt and short-term assets cover both long-term and short-term liabilities. However, the company faces challenges with declining earnings over the past five years and low return on equity at 1.5%. The dividend payout is not well covered by earnings despite high-quality earnings overall. Recent board changes may bring strategic shifts but do not immediately address profitability concerns or improve net profit margins, which have decreased from 1.9% to 1.4% over the last year.</p>
<div class="lb-trans"><p>InnoTek Limited，市值为 1.7263 亿新加坡元，展现出财务韧性，因为其现金储备超过总债务，短期资产覆盖长期和短期负债。然而，该公司面临过去五年盈利下降的挑战，股本回报率仅为 1.5%。尽管整体盈利质量较高，但股息支付并未得到盈利的良好支持。最近的董事会变动可能带来战略转变，但并未立即解决盈利能力问题或改善净利润率，后者在过去一年中从 1.9% 降至 1.4%。</p>
</div><ul>
<li>Jump into the full analysis health report here for a deeper understanding of InnoTek.</li>
<li>Understand InnoTek's track record by examining our performance history report.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击此链接查看 InnoTek 的完整分析健康报告，以深入了解该公司。</li>
<li>通过查看我们的业绩历史报告，了解 InnoTek 的过往表现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/12da91b7-f162-4c43-bee1-d9294ba5d487/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/12da91b7-f162-4c43-bee1-d9294ba5d487/chart/debt-equity-history-analysis"/></p>
<p>SGX:M14 Debt to Equity History and Analysis as at Jan 2026</p>
<div class="lb-trans"><p>截至 2026 年 1 月的 SGX:M14 债务与股本历史及分析</p>
</div><h2>Turning Ideas Into Actions</h2>
<div class="lb-trans"><h2>将想法转化为行动</h2>
</div><ul>
<li>Click this link to deep-dive into the 947 companies within our Asian Penny Stocks screener.</li>
<li>Want To Explore Some Alternatives? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击此链接深入了解我们亚洲便士股票筛选器中的 947 家公司。</li>
<li>想要探索一些替代方案？通过提供可靠收入来源的稳健股息支付者来多样化您的投资组合，以应对潜在的市场动荡。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>本文由 Simply Wall St 撰写，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，采用无偏见的方法，我们的文章并不构成财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均没有持仓。</em></p>
</div>

三只市值低于 20 亿美元的亚洲便士股